Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Medicinal Research Reviews|April 3, 2008
Selective inhibitors of picornavirus replicationArmando M De Palma, Inge Vliegen, Erik De Clercq, et al.Microbes and Infection|January 24, 2004
Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activationInge Vliegen, Ad Duijvestijn, Gert Grauls, et al.Journal of Microbiological Methods|December 24, 2005
Rapid identification of bacteria by real-time amplification and sequencing of the 16S rRNA geneInge Vliegen, Jan A Jacobs, Erik Beuken, et al.Current Topics in Microbiology and Immunology|March 7, 2013
Hepatitis C virus-specific directly acting antiviral drugsLeen Delang, Johan Neyts, Inge Vliegen, et al.Antimicrobial Agents and Chemotherapy|December 24, 2008
Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitorsLotte Coelmont, Suzanne Kaptein, Jan Paeshuyse, et al.Atherosclerosis|June 9, 2005
Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic miceInge Vliegen, Selma B Herngreen, Gert E L M Grauls, et al.Hepatology (Baltimore, Md.)|May 14, 2009
Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance developmentLeen Delang, Jan Paeshuyse, Inge Vliegen, et al.Biochemical and Biophysical Research Communications|August 1, 2006
Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisininJan Paeshuyse, Lotte Coelmont, Inge Vliegen, et al.Antiviral Research|November 6, 2007
Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agentsJih Ru Hwu, Raghunath Singha, Shih Ching Hong, et al.Antimicrobial Agents and Chemotherapy|July 16, 2008
Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitorsJan Paeshuyse, Inge Vliegen, Lotte Coelmont, et al.Pageof 3